http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-288042-B6

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f5033fcf56d5a13743728cc85a8dc3f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
filingDate 1996-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3386b61e3a6b952d25acc3d003da7e7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71b283d89c8b7276d6142b5baede3c32
publicationDate 2001-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CZ-288042-B6
titleOfInvention Process for preparing enantiomerically pure imidazolyl compounds and an imidazolyl compound
abstract The present invention relates to a process for the preparation of enantiomerically pure imidazolyl compounds of formula I wherein n is 0 or 1, m is 1 or 2, R is 1. is hydrogen, methyl or ethyl and C * is a chiral center, as well as pharmaceutically acceptable acid addition salts thereof, wherein a carboxylic acid in an optically active form is added to a solution of the racemic mixture of formula I, followed by In the first crystallization, the crystallized addition salt of said mixture of enantiomers of the compound of formula I is enriched with one enantiomer from the mother liquor enriched in the second enantiomer, wherein the carboxylic acid is pyroglutamic acid. The present invention also relates to an imidazolyl compound of the formula I wherein n and m are 1, R &lt; 1 &gt; is methyl and C * has the R configuration, in the form of hydrochloride monohydrate, having in particular improved resistance to the presence of lubricants.
priorityDate 1995-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415866247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414002843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159582948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453625151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21885828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415758420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID179741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21962138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67943844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407698407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450873103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448478793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4595
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415911763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548926

Total number of triples: 61.